Laurus Labs Limited
LAURUSLABS
Pozycja w akcjach
#1745
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Cena akcji
$22.83
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$12.34B
Zmiana (1 dzień)
0.51%
Zmiana (1 rok)
117.95%
Kraj
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategoria
Healthcare
Zyski dla Laurus Labs Limited (LAURUSLABS)
Zyski w Jun 2026 TTM: $158.77M
Według najnowszych raportów finansowych Laurus Labs Limited, obecny zysk firmy wynosi $158.77M. W roku 2024 firma osiągnęła zysk w wysokości $27.63M, spadek w porównaniu do zysku z roku 2023, który wynosił $134.55M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Laurus Labs Limited od 2013 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $158.77M | 178.14% |
| 2025 | $57.08M | 106.57% |
| 2024 | $27.63M | -79.46% |
| 2023 | $134.55M | -5.75% |
| 2022 | $142.76M | -19.68% |
| 2021 | $177.74M | 356.04% |
| 2020 | $38.97M | 126.00% |
| 2019 | $17.25M | -52.71% |
| 2018 | $36.46M | 0.99% |
| 2017 | $36.11M | 41.84% |
| 2016 | $25.45M | 137.71% |
| 2015 | $10.71M | -3.94% |
| 2014 | $11.15M | -29.65% |
| 2013 | $15.85M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,011.36% |
IN
|
